Double maintains 2 strategies that include IBRX - ImmunityBio, Inc.
Current Value
$2.971 Year Return
Current Value
$2.971 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -23.49% | $416.76M | 1.43% |
VIXY | -17.78% | $195.31M | 0.85% |
DBA | -11.69% | $829.48M | 0.93% |
TPMN | -11.60% | $33.32M | 0.65% |
TAIL | -11.59% | $87.65M | 0.59% |
UUP | -11.32% | $325.79M | 0.77% |
USDU | -10.65% | $206.96M | 0.5% |
AFIF | -9.82% | $135.91M | 1.11% |
DBE | -9.80% | $55.52M | 0.77% |
CCOR | -9.45% | $64.12M | 1.18% |
WEAT | -8.98% | $115.75M | 0.28% |
CORN | -8.19% | $52.17M | 0.2% |
USO | -8.05% | $972.70M | 0.6% |
DBO | -8.00% | $202.41M | 0.77% |
UGA | -7.91% | $87.23M | 0.97% |
BNO | -7.50% | $99.25M | 1% |
OILK | -6.82% | $67.85M | 0.69% |
USL | -6.75% | $47.77M | 0.85% |
GSG | -6.60% | $1.05B | 0.75% |
KRBN | -6.45% | $175.08M | 0.85% |
Yahoo
The United States market has experienced a flat performance over the last week, yet it has seen an 8.4% rise over the past year, with earnings forecasted to grow by 14% annually. In this context of steady growth expectations, identifying high-growth tech stocks involves looking for companies with innovative technologies and strong potential to capitalize on future trends.
Yahoo
CULVER CITY, Calif., March 26, 2025--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, invites current and prospective investors to its Investor Day program to be held on Tuesday, April 15, 2025, at 10:00 am PDT. The program will include an in-depth update on the company’s business operations and recent R&D advancements. Key timelines for catalysts of product candidates will be presented, along with a discussion of ongoing clinical trials.
Finnhub
CULVER CITY - ImmunityBio, Inc. , a leading immunotherapy company, today announced U.S. Urology Partners, one of the nation's largest independent providers of urology and related specialty services,...
Yahoo
CULVER CITY, Calif., March 13, 2025--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced U.S. Urology Partners, one of the nation’s largest independent providers of urology and related specialty services, is one of the first providers to participate in ImmunityBio’s Expanded Access Program (EAP) for recombinant Bacillus Calmette-Guérin (rBCG) to address the current shortage of TICE® BCG in the U.S.
Yahoo
As of March 2025, the U.S. stock market is experiencing increased volatility, with significant corrections in major indices like the Nasdaq Composite due to ongoing trade policy uncertainties and concerns over high valuations. Amid these turbulent conditions, growth companies with high insider ownership often attract attention because their stakes suggest a strong alignment between management and shareholder interests, potentially offering resilience in challenging economic climates.
SeekingAlpha
ImmunityBio (IBRX) faces operational, financial, and competitive challenges, impacting its growth prospects despite Anktiva's potential. See more here.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 38.26% | $4.76B | 0.35% |
ETH | 35.68% | $1.29B | 0% |
PTH | 35.14% | $107.91M | 0.6% |
ARKG | 34.27% | $936.86M | 0.75% |
ETHW | 34.16% | $178.76M | 0% |
ETHA | 33.95% | $2.27B | 0.25% |
QETH | 33.81% | $14.36M | 0.25% |
ETHV | 33.73% | $87.97M | 0% |
EZET | 33.73% | $22.46M | 0% |
CETH | 33.70% | $10.49M | 0% |
FETH | 33.53% | $762.75M | 0.25% |
PBE | 33.08% | $224.98M | 0.58% |
RSPA | 32.77% | $292.67M | 0% |
IBB | 32.73% | $5.61B | 0.45% |
GNOM | 32.15% | $47.13M | 0.5% |
CPRJ | 31.98% | $48.38M | 0.69% |
ERTH | 31.66% | $138.98M | 0.67% |
PBW | 31.12% | $213.72M | 0.65% |
QCLN | 30.30% | $399.59M | 0.59% |
PINK | 30.29% | $138.92M | 0.5% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
FXY | 0.08% | $549.84M | 0.4% |
BCI | -0.11% | $1.45B | 0.26% |
GCC | -0.14% | $149.77M | 0.55% |
IBD | 0.20% | $382.70M | 0.44% |
YEAR | 0.22% | $1.28B | 0.25% |
KCCA | 0.43% | $108.04M | 0.87% |
ICLO | -0.47% | $354.74M | 0.2% |
JMST | 0.50% | $3.54B | 0.18% |
KMLM | 0.65% | $218.49M | 0.9% |
FBY | 0.79% | $151.21M | 1.06% |
BSMR | -0.84% | $235.44M | 0.18% |
CTA | -0.90% | $978.30M | 0.76% |
ULST | 0.99% | $585.14M | 0.2% |
CANE | 1.10% | $11.28M | 0.29% |
EIDO | 1.20% | $277.10M | 0.59% |
SOYB | -1.51% | $26.08M | 0.22% |
CMBS | 1.59% | $432.98M | 0.25% |
BIL | 1.60% | $41.88B | 0.1356% |
USTB | 1.82% | $1.14B | 0.35% |
CMDY | 1.85% | $313.96M | 0.28% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
KNSL | -21.15% | $11.44B | +8.46% | 0.13% |
TNET | -18.49% | $3.94B | -40.45% | 1.35% |
WKC | -16.10% | $1.61B | +7.99% | 2.54% |
PDCO | -12.98% | $2.77B | +17.86% | 2.49% |
CBOE | -9.81% | $23.50B | +25.53% | 1.05% |
EQC | -9.43% | $170.80M | +24.66% | 0.00% |
SKWD | -9.05% | $2.20B | +43.19% | 0.00% |
HCA | -9.01% | $85.44B | +4.46% | 0.77% |
HIHO | -8.82% | $7.92M | -15.09% | 6.67% |
HIG | -8.72% | $35.63B | +22.27% | 1.60% |
CPRI | -7.84% | $2.31B | -56.66% | 0.00% |
THC | -5.97% | $13.05B | +33.07% | 0.00% |
BTCT | -5.77% | $20.15M | +14.57% | 0.00% |
DXCM | -5.61% | $26.63B | -50.81% | 0.00% |
TS | -5.32% | $21.62B | -2.61% | 3.70% |
PRG | -5.31% | $1.14B | -14.76% | 1.92% |
OIS | -5.23% | $323.11M | -18.34% | 0.00% |
AON | -5.16% | $85.54B | +22.05% | 0.68% |
PRPO | -5.15% | $8.36M | -11.96% | 0.00% |
RES | -5.01% | $1.24B | -28.23% | 3.26% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CGEM | 36.33% | $457.57M | -54.53% | 0.00% |
ROG | 33.80% | $1.29B | -40.33% | 0.00% |
DAWN | 31.46% | $807.80M | -48.91% | 0.00% |
OCUL | 31.07% | $1.17B | -13.14% | 0.00% |
RXRX | 31.02% | $2.13B | -40.76% | 0.00% |
EYPT | 30.93% | $369.07M | -74.12% | 0.00% |
CLRB | 30.76% | $13.92M | -92.41% | 0.00% |
EXPO | 30.19% | $4.15B | +2.23% | 1.45% |
KRYS | 30.00% | $5.21B | +1.76% | 0.00% |
RMD | 29.93% | $32.75B | +19.87% | 0.97% |
VRA | 29.91% | $63.57M | -65.12% | 0.00% |
ANAB | 29.81% | $581.75M | -8.45% | 0.00% |
TPC | 29.64% | $1.23B | +48.30% | 0.00% |
DLR | 29.44% | $50.05B | +5.72% | 3.47% |
SEG | 29.23% | $269.93M | -17.45% | 0.00% |
ACRS | 29.00% | $166.20M | +23.20% | 0.00% |
BPMC | 28.44% | $5.75B | -2.41% | 0.00% |
SNAP | 28.35% | $15.06B | -20.36% | 0.00% |
KALV | 28.35% | $551.35M | -1.51% | 0.00% |
NWL | 28.34% | $2.61B | -16.84% | 4.94% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SU | -0.01% | $48.41B | +1.58% | 4.27% |
WWW | -0.02% | $1.18B | +43.14% | 3.38% |
RRC | -0.03% | $9.80B | +15.57% | 0.87% |
PB | 0.04% | $6.81B | +13.76% | 3.41% |
SAND | -0.04% | $2.22B | +35.93% | 0.76% |
CYH | -0.05% | $372.04M | -14.52% | 0.00% |
EW | -0.05% | $42.20B | -22.54% | 0.00% |
UUU | 0.06% | $4.14M | +11.18% | 0.00% |
LUMN | 0.09% | $4.12B | +183.10% | 0.00% |
DV | 0.09% | $2.22B | -59.89% | 0.00% |
ALL | 0.10% | $54.44B | +18.46% | 1.83% |
OSPN | -0.10% | $593.63M | +31.00% | 0.83% |
AEP | -0.10% | $57.54B | +27.77% | 3.31% |
PG | -0.11% | $397.45B | +8.55% | 2.32% |
LITB | 0.11% | $41.93M | -46.48% | 0.00% |
KR | -0.12% | $48.68B | +16.46% | 1.77% |
GPI | -0.14% | $5.20B | +42.90% | 0.53% |
GORV | -0.14% | $32.00M | -92.53% | 0.00% |
AMSF | 0.14% | $997.00M | +13.96% | 2.88% |
CRI | -0.15% | $1.52B | -47.46% | 8.87% |